BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7292160)

  • 1. [Radioactive iodine in the treatment of thyroid carcinoma].
    Pendić S; Tasić S
    Srp Arh Celok Lek; 1980 Oct; 108(10):1021-9. PubMed ID: 7292160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indications for and against the treatment of thyroid cancer with radioactive iodine].
    Wieckowski B; Skrzypek J
    Pol Tyg Lek; 1983 Apr; 38(16):501-3. PubMed ID: 6634495
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience in the management of thyroid carcinoma by I-131. A report of 39 cases.
    Bricout P; Kibler RS
    J Can Assoc Radiol; 1973 Dec; 24(4):323-7. PubMed ID: 4773908
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
    Vassilopoulou-Sellin R; Schultz PN; Haynie TP
    Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Necessity to administer 131I in a patient with papillary thyroid carcinoma undergoing chronic hemodialysis].
    Novik V; González R; Díaz M; Vega J
    Rev Med Chil; 1998 Jul; 126(7):874-5. PubMed ID: 9830782
    [No Abstract]   [Full Text] [Related]  

  • 6. [Malignant goiter. Retrospective analysis of the patient material and treatment results at the Division of Nuclear Medicine of the 2nd Medical Department of Vienna University from 1973 to 1982].
    Weissel M; Bergmann H; Steidler B; Keminger K; Krisch K; Niederle B; Roka R; Schmalzer E; Willvonseder R; Höfer R
    Acta Med Austriaca; 1983; 10(2-3):83-91. PubMed ID: 6880577
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of papillary carcinoma of the thyroid occurring after irradiation.
    Crile G
    Surg Gynecol Obstet; 1980 Jun; 150(6):850-2. PubMed ID: 7376046
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of thyroid malignancies with radioiodine [proceedings].
    Cottino F
    J Nucl Med Allied Sci; 1977; 21(1-2):55-6. PubMed ID: 915550
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of thyroid cancer in childhood and adolescence from a radiologic viewpoint].
    Gottschild D; Zinner G; Langbein T; Newmann G; Wünsche A; Schneider G
    Radiobiol Radiother (Berl); 1986; 27(6):709-20. PubMed ID: 3575679
    [No Abstract]   [Full Text] [Related]  

  • 10. Iodine-131 therapy of thyroid cancer: extensive contamination of the hospital room in a patient with tracheostomy.
    Kappes RS; Sarkar SD; Har-El G; Strashun AM; Dunn EK; Schussler GC
    J Nucl Med; 1994 Dec; 35(12):2053-4. PubMed ID: 7989991
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic strategy in thyroid carcinoma].
    Baschieri L; Antonelli A; Del Guerra P
    Clin Ter; 1987 Jun; 121(6):457-65. PubMed ID: 2973881
    [No Abstract]   [Full Text] [Related]  

  • 12. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.
    Chow SM; Yau S; Kwan CK; Poon PC; Law SC
    Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years.
    Brierley J; Tsang R; Panzarella T; Bana N
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):418-27. PubMed ID: 16181234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should radioactive iodine therapy be administrated in patient of papillary thyroid carcinoma?
    Zhao J; Dong J; Sun Q; Wang H; Zhang Z; Zhou X; Liao L
    Chin Med J (Engl); 2014; 127(16):3039-40. PubMed ID: 25131255
    [No Abstract]   [Full Text] [Related]  

  • 16. Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication.
    Allweiss P; Braunstein GD; Katz A; Waxman A
    J Nucl Med; 1984 Jul; 25(7):755-8. PubMed ID: 6737074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thyroid papillary microcarcinoma. Salah Azaiz Institute experience].
    Oueslati Z; Aloui M; Gritli S; Touati S; el-May A; Gamoudi A; Ben-Slimene F; Ladgham A
    Rev Laryngol Otol Rhinol (Bord); 2002; 123(1):39-42. PubMed ID: 12200999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodine-131 treatment of thyroid cancer: relation between effective half-life and efficacy of treatment.
    Matsushita T; Toyota S; Katoh N; Nakagawa T
    Radiat Med; 1994; 12(4):167-70. PubMed ID: 7809410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas ligand (FasL, Apo-1L/CD95L) expression and clinical outcome in papillary microcarcinoma and papillary thyroid carcinomas with diameter smaller than 1.5 centimeters.
    Bayraktaroglu T; Boztepe H; Kapran Y; Tanakol R; Alagöl F
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):537-43. PubMed ID: 20013612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of radioactive iodine therapy in young patients with papillary thyroid cancer.
    Kuo SF; Chao TC; Chang HY; Hsueh C; Chang YC; Yang CH; Lin JD
    Clin Nucl Med; 2009 Jan; 34(1):4-6. PubMed ID: 19092372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.